West Pharmaceutical Services Inc
WST· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $346.80M | $339.40M | $316.30M | $295.40M |
| Net Income | $27.10M | $31.70M | $29.20M | $19.60M |
| EPS Diluted | $0.38 |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $0.45 |
| $0.81 |
| $0.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.